Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Metabolic acidosis |Aspirin or Salicylates toxicity |Ethylene glycol toxicity |Renal Tubular Acidosis |Pyroglutamic acidosis |Lactic acidosis
Thin, weak, muscle aches
Extra strength Q2 she takes
Large anion gap
@DrCindyCooper
Pyroglutamic acidosis. Elevated pyroglutamic acid is an example of an endogenous acid. Seen in those who are already glutathione-depleted
Category | Causes | Mechanism |
---|---|---|
Genetic Disorders |
|
Inherited enzyme deficiencies disrupt the gamma-glutamyl cycle, leading to accumulation of 5-oxoproline. |
Medication-Induced |
|
Acetaminophen depletes glutathione, leading to increased production of pyroglutamic acid. Some antibiotics can alter glutathione metabolism, leading to accumulation of 5-oxoproline. |
Critical Illness |
|
Increased oxidative stress and compromised detoxification pathways result in 5-oxoproline accumulation. |
Dietary Factors |
|
Imbalance in amino acids necessary for glutathione synthesis can lead to accumulation of pyroglutamic acid. |
Metabolic Conditions |
|
Metabolic stressors increase the demand for glutathione, leading to its depletion and subsequent pyroglutamic acidosis. |
Test | Causes | Mechanism |
---|---|---|
Blood Gas Analysis | ABG to check for high anion gap metabolic acidosis. | Confirms the presence of metabolic acidosis, a key feature of pyroglutamic acidosis. |
U&E and Anion Gap | Check U&E to calculate the anion gap. | Diagnosis supported by elevated anion gap metabolic acidosis due to an accumulation of pyroglutamic acid. |
Urine Organic Acids | Check urine organic acid analysis using gas chromatography-mass spectrometry (GC-MS). | Confirms the diagnosis by directly measuring the elevated pyroglutamic acid levels. |
Plasma 5-Oxoproline Levels | Confirms the diagnosis.Elevated plasma levels of 5-oxoproline are diagnostic of pyroglutamic acidosis. | |
Toxicology Screening | Conduct a toxicology screen to identify acetaminophen overdose or other substances. | Check for medication-induced pyroglutamic acidosis. |
Assessment of Liver Function | Perform liver function tests (LFTs) to assess the liver function. | Liver dysfunction can contribute to impaired metabolism and detoxification. |
Management Step | Details | Rationale |
---|---|---|
Discontinuation of Causative Agents | Stop acetaminophen/other drugs contributing to glutathione depletion. | Removing the source of glutathione depletion halts the overproduction of pyroglutamic acid. |
Glutathione Repletion | Administer N-acetylcysteine (NAC) IV/PO. | NAC replenishes glutathione stores and reduces pyroglutamic acid levels. |
Correction of Metabolic Acidosis | Consider sodium bicarbonate infusion if severe acidosis is present. | Helps buffer the excess acid, preventing complications from severe acidosis. |
Supportive Care | Ensure adequate hydration with IV fluids. Monitor U&E regularly. | Hydration helps clearance of pyroglutamic acid. |
Treatment of Underlying Conditions | Treat illnesses (e.g., infection, sepsis) that may have triggered the condition. | Reduce metabolic stress that contributes to pyroglutamic acidosis. |
Monitoring and Follow-Up | Regularly monitor blood pH, anion gap, and 5-oxoproline levels until stabilized. | Ensures that the treatment is effective and the patient is recovering. |